1- Licea ME, Acosta A, Álvarez VA, Aldana D, Arnold Y, Álvarez Y, et al. Diabetes mellitus. Una mirada integral. La Habana: Editorial Ciencias Médicas; 2021. 848 p. ISBN 978-959-313-883-3. Disponible en: http://www.bvscuba.sld.cu/libro/diabetes-mellitus-una-mirada-integral//
2- Bess S, Alonso I, Sánchez E, López LM, editores. Anuario estadístico de salud 2019. La Habana: Ministerio de Salud Pública. Dirección de registros médicos y estadísticas de salud; 2020. 193 p. ISSN 1561-4433. Disponible en: http://files.sld.cu/bvscuba/files/2020/05/Anuario-Electrónico-Español-2019-ed-2020.pdf
3- Yu L, Zeng XL, Cheng ML, Yang GZ, Wang B, Xiao ZW, et al. Quantitative assessment of the effect of pre-gestational diabetes and risk of adverse maternal, perinatal and neonatal outcomes. Oncotarget. 2017; 8 (37); 61048-56. DOI: 10.18632/oncotarget.17824.
4- Ornoy A, Reece EA, Pavlinkova G, Kappen C, Kermit R. Effect of maternal diabetes on the embryo, fetus, and children: congenital anomalies, genetic and epigenetic changes and developmental outcomes. Birth Defects Research (Part C). 2015; 105: 53-72. DOI:10.1002/bdrc.21090.
5- Eriksson UJ, Wentzel P. The status of diabetic embryopathy Upsala Journal of Medical Sciences. 2015; 121 (2): 96 -112. DOI:10.3109/03009734.2016.1165317.
6- Loeken MR. Mechanisms of congenital malformations in pregnancies with pre-existing diabetes. Curr Diab Rep. 2020; 20 (10): 54. DOI:10.1007/s11892-020-01338-4.
7- Suresh S, Rajvanshi PK and Noguchi CT. The many facets of erythropoietin physiologic and metabolic response. Front Physiol. 2020 Jan; 10:1534. DOI:10.3389/fphys.2019.01534.
8- Chen Z-Y, Asavaritikrai P, Prchal JT, Noguchi CT. Endogenous
erythropoietin signaling is required for normal neural progenitor cell
proliferation. J Biol Chem. 2007; 282 (35): 25875–83. DOI:10.1074/jbc.M701988200.
9- Ji YQ, Zhang YQ, Li MQ, Du MR, Wei WW, Li DJ. EPO improves the
proliferation and inhibits apoptosis of trophoblast and decidual stromal
cells through activating STAT-5 and inactivating p38 signal in human
early pregnancy. Int J Clin Exp Pathol. 2011;4(8): 765-74. Epub 2011 Nov 3. PMID: 22135724; PMCID: PMC3225788.
10- Niu HS, Shan Ch, Niu Sh, Cheng J, Lee K. Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats. Drug Des Dev Ther. 2016 Jun 3; 10:1877-84. DOI:10.2147/DDDT.S1058677.
11- Kuo Sh, Li Y, Cheng KcH, Niu Ch, Cheng J, Niu H. Investigation of the pronounced erythropoietin-induced reduction in hyperglycemia in type 1-like diabetic rats. Endocr J. 2018 Feb 26; 65 (2):181-91. DOI:10.1507/endocrj.EJ17-0353.
12- EL Okela AZ, El-Arbagyb AR, Yasseinb YS, Khodirc, Kasemb HE. Effect of erythropoietin treatment on hemoglobin A1c levels in diabetic patients with chronic kidney disease. J Egypt Soc Nephrol Transplant. 2019; 19 (3):86-94. DOI:10.4103/jesnt.jesnt_2_19.
13- Peng B, Kong G, Yang C, Ming Y. Erythropoietin and its derivatives: from tissue protection to immune regulation. Cell Death Dis. 2020 Feb; 11(2):2-12. DOI:10.1038/s41419-020-2276-8.
14- Garzón F, Rodríguez Y, García JC, Rama R. Neuroprotective effects of NeuroEPO using an in vitro model of stroke. Behav Sci (Basel). 2018 Feb 13; 8 (26):1-11. DOI:10.3390/bs8020026.
15- Garzón F, Coimbra D, Parcerisas A, Rodriguez Y, García JC, Soriano E, et al. NeuroEPO preserves neurons from glutamate-induced excitotoxicity. J Alzheimers Dis. 2018; 65 (4):1469-83 DOI:10.3233/JAD-180668.
16- Rama R, Garzón F, Rodríguez-Cruz Y, Maurice T, García-Rodríguez JC. Neuroprotective effect of Neuro-EPO in neurodegenerative diseases: “Alea jacta est”. Neural Regen Res. 2019 Sep; 14(9):1519-21. DOI:10.4103/1673-5374.255968.
17- Rodríguez Y, Strehaiano M, Rodríguez T, García JC, Maurice T. An intranasal formulation of erythropoietin (Neuro-EPO) prevents memory deficits and amyloid toxicity in the APPSwe transgenic mouse model of Alzheimer’s disease. J Alzheimer´s Dis. 2017; 55(1):231-48. DOI:10.3233/JAD-160500.
18- Fernández Romero T, Clapés Hernández S, Pérez Hernández CL, Barreto López JJ, Fernández Peña G. Efecto hipoglicemiante de la NeuroEPO en ratas con y sin diabetes mellitus. Rev haban cienc méd [Internet]. 2022 [citado]; 21(1):e4617.Disponible en:
http://www.revhabanera.sld.cu/index.php/rhab/article/view/4617
19- Yilmaz O, Lambrecht FY, Gokmen N, Erbayraktar S, Durkan K. Distribution of 131I-labeled recombinant human erythropoietin in maternal and fetal organs following intravenous administration in pregnant rats. Journal of Radioanalytical and Nuclear Chemistry. 2007; 273 (2): 311–3. DOI:10.1007/s10967-007-6859-y
20- Kaushik K, Vaswani R. Research on animals and current UGC guidelines on animal dissection and experimentation: A critical analysis. Bioethics Update. 2018; 4(2):119-39. DOI:org/10.1016/j.bioet.2018.05.001.
21- McCormick-Ell J, Connell N. Laboratory safety, biosecurity and responsible animal use. ILAR J. 2019 Dec 31; 60(1):24-33. DOI: 10.1093/ilar/ilz012.
22- Sinzato YK, Kloppel E, Miranda CA, Paula VG, Alves LF, Nascimento LLS, et al. Comparison of streptozotocin-induced diabetes at different moments of the life of female rats for translational studies. Laboratory Animals. 2021; 0(0): 1-11. DOI:10.1177/00236772211001895.
23- Karwasik-Kajszczarek K, Chmiel-Perzyńska I, Marcin J, Billewicz-Kraczkowska A, Pedrycz A, Smoleń A, et al. Impact of experimental diabetes and chronic hypoxia on rat fetal body weight. Ginekologia Polska. 2018; 89 (1): 20 -4. DOI:10.5603/GP.a2018.0004.
24- Quinna NA, Badwan AA. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug Design, Development and Therapy. 2015 May 5; 9 2515–25. DOI:10.2147/DDDT.S79885.
25- Fernández T, Suárez G, Clapés S. Protocolo para la citología vaginal directa de ratas de laboratorio. Rev haban cienc méd [Internet]. 2021; 20(3): e4086. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/4086
26- Fernández T, Clapés S, Suárez G, Perera A, Rodríguez VM, Purón CA, et al. Embriopatía diabética en ratas y efecto de un suplemento nutricional de vitamina E durante la gestación. Rev haban cienc méd [Internet]. 2013; 12(2): [aprox.0p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/56
27- Fernández Romero, Tammy; Clapes, Sonia; Pérez, Carlos L; Núñez López, Nínive ; Suárez Román, Gipsis ; Fernández, Gisselle (2022), “Protective effect of NeuroEPO on the reproduction of diabetic rats.”, [Internet]. Amsterdam: Mendeley Data, V1, doi: 10.17632/dvk9rtwccy.1 Disponible en: https://data.mendeley.com/datasets/ dvk9rtwccy/1
28- Pan Y, Hong X, Li L, Hong Y, Yan Q, Min H, et al. Erythropoietin reduces insulin resistance via regulation of its receptor-mediated signaling pathways in db/db mice skeletal muscle. Int J Biol Sci. 2017 Oct 17; 13 (10):1329-40. DOI:10.7150/ijbs.19752
29- El-Desouki NI, Tabl GA, Abdel-Aziz KK, Salim EI, Nazeeh N. Improvement in beta-islets of Langerhans in alloxan-induced diabetic rats by erythropoietin and spirulina. The Journal of Basic and Applied Zoology. 2015; 71: 20-31. DOI:10.1016/j.jobaz.2015.04.003
30- Chen L, Sun Q, Liu S, Hu H, Lv J, Ji W, et al. Erythropoietin improves glucose metabolism and pancreatic β-cell damage in experimental diabetic rats. Molecular Medicine Reports. 2015; 12: 5391-98. DOI:10.3892/mmr.2015.4006
31- Goyal SN, Reddy NM, Patil KR, Nakhate KT, Ojha S, Patil CR, et al. Challenges and issues with streptozotocin-induced diabetes- A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chemico-Biological Interactions. 2016; 244 (2016) 49-63. DOI:org/10.1016/j.cbi.2015.11.032
32- Jawerbaum A, White V. Animal models in diabetes and pregnancy. Endocrine Reviews. 2010; 31(5): 680–701. DOI:10.1210/er.2009-0038
33- Weishaupt JH, Rohde G, Pölking E, Siren AL, Ehrenreich H, Bähr M. Effect of Erythropoietin Axotomy-Induced Apoptosis in Rat Retinal Ganglion Cells. Invest Ophthalmol Vis Sci. 2004 May 1;45(5):1514–22.
34- Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell’Era P, et al. Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo. Blood. 1999 Apr 15;93(8):2627–36.
35- Teste IS, Tamos YM, Cruz YR, Cernada AM, Rodríguez JC, Martínez NS, et al. Dose effect evaluation and therapeutic window of the neuro-EPO nasal application for the treatment of the focal ischemia model in the Mongolian gerbil. ScientificWorldJournal [Internet]. 2012;2012:607498. Available from: http://europepmc.org/abstract/MED/22701364
36- Voss AK, Strasser A. The essentials of developmental apoptosis. F1000Research [Internet]. 2020 [cited 2022 Jul 29];9. Available from: /pmc/articles/PMC7047912/